Physician profile
Michele D Lee
NPI 1396164299
$7,459.46
in general payments reported to CMS, 2019-2025
27 companies · $2,211 in 2025
The $2,211 reported for 2025 was more than what 85% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $527 · 2020: $58.31 · 2021: $487 · 2022: $1,389 · 2023: $1,413 · 2024: $1,374 · 2025: $2,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,966 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,965.89 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $1,897.25 | 2020-2025 | Idosetr, Idose, Istent Infinite |
| Alcon Vision LLC | $1,194.34 | 2019-2025 | Clareon, Clareon Panoptix Pro, Tryptyr |
| Bausch & Lomb Americas INC. | $878.61 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Sun Pharmaceutical Industries INC. | $504.46 | 2019-2025 | Bromsite, Cequa, Xelpros |
| Dompe US, INC. | $424.50 | 2019-2025 | Oxervate |
| Johnson & Johnson Surgical Vision, INC. | $280.32 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $243.40 | 2021-2023 | |
| Abbvie INC. | $239.77 | 2023-2025 | |
| Amgen INC. | $229.41 | 2024-2025 | Tepezza |
| Carl Zeiss Meditec USA, INC. | $218.67 | 2023-2024 | |
| Allergan, INC. | $180.30 | 2022 | |
| Oyster Point Pharma, INC. | $171.19 | 2022-2023 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $168.20 | 2024 | Xdemvy |
| Rxsight INC | $136.05 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Mallinckrodt Enterprises LLC | $124.96 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $105.61 | 2023-2025 | Vevye, Iheezo |
| Rayner Intraocular Lenses Limited | $77.26 | 2024 | Rayone Spheric, Rayone Emv, Rayone Aspheric |
| Biotissue Holdings INC. | $64.18 | 2024 | |
| Mallinckrodt Hospital Products INC. | $62.96 | 2020-2025 | Acthar |
| Carl Zeiss Meditec, INC. | $57.26 | 2021 | |
| Sight Sciences, INC. | $50.06 | 2021 | |
| Kala Pharmaceuticals, INC. | $35.09 | 2021-2022 | |
| Akorn Operating Company LLC | $32.43 | 2021 | |
| New World Medical,INC. | $27.69 | 2024-2025 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Aerie Pharmaceuticals, INC. | $23.75 | 2021 | |
| Ocular Therapeutix, INC. | $17.20 | 2025 | Dextenza |
| Thea Pharma INC. | $14.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.